Treatment of syringoma using an ablative 10,600nm carbon. Treatment, removal, and what to expect after surgery. To further characterize pilosebaceous differentiation and to identify the presence of merkel cells in the areas of follicular differentiation. It presents as a firm, dermal or subcutaneous nodule, usually between 0.
They were initially described by kaposi in 1872 as lymphangioma. They are usually found on your upper cheeks and lower eyelids. Syringomas are benign eccrine sweat duct tumors, typically found clustered on eyelids. Epithelial components derived from folliculosebaceousapocrine germ are evident in apocrine but not in eccrine cs. It is also called as mixed tumor of skin because of the presence of. Only one patient out of ten was suspected of recurrence in follow. Chondroid syringoma is also known as mixed tumour of the skin.
The clinicopathology of cases of chondroid syringoma were examined. Chondroid syringoma is a rare benign skin adnexal tumor of eccrineapocrine origin affecting commonly the head and neck region. Chondroid syringoma is a tumor arising from the sweat glands which can be apocrine found throughout the surface of lid or eccrine glands of moll in association with eyelash follicles with a mean age of 50 years 2273 years. Hirsch and helwig named it chondroid syringoma because of the presence of sweat gland elements in a cartilaginous stroma and the histological criteria for diagnosis. Giant chondroid syringoma of the lower eyelid ncbi nih. Hilton, state health laboratory services of western australia, and department of pathology, st john of god hospital, subiaco, western australia. The ages of the patients ranged from 26 to 86 years, with an average of 48 years. Ten tumors out of the thirteen appeared on the face. Chondroid syringoma, or cutaneous mixed tumor, is an adnexal neoplasm of either apocrine or eccrine origin. Methods thirtyfive patients with periorbital syringomas were treated with two sessions of co2 fs at. Chondroid syringoma cs is a benign cutaneous adnexal tumor with epithelial and stromal components.